About
We are My Life Spark, P.C.
A physician-owned medical practice and the operating company behind the country's first medically-serious GLP-1 and metabolic health franchise. Founded by clinicians who watched the compounding boom fail their patients — and decided to build the alternative.
Our Thesis
Metabolic health is the largest unmet medical demand in a generation — and nobody has built the operator.
GLP-1 receptor agonists are the largest therapeutic launch in pharmaceutical history. Twelve million American adults are now on them, and demand is doubling annually. Yet the average patient receives less than twelve minutes of physician time, no body composition assessment, no muscle-preservation protocol, and no cardiometabolic workup. They lose lean mass, regain weight, and never get the full benefit of the medication.
The compounding crackdown of 2025 closed the gray-market shortcut. Six million patients are looking for a legitimate, branded, physician-led home for their care. None of the existing categories — med-spas, telehealth coupon shops, or 12-minute primary care — can deliver it.
My Life Spark is the operator that category requires. A physician-owned PC structure, compliant in every state. A clinical protocol — the Life Spark Survivorship Protocol™ — authored by board-certified internists and endocrinologists. A franchise model purpose-built to scale a medically rigorous brand across 250 clinics and 75 DMAs.
We are not a wellness brand. We are a medical practice that happens to scale like a category-defining consumer brand.
Clinical Advisory Board
Survivorship, authored by people who practice it.
Board-certified physicians authoring every protocol. Pharmacists overseeing deprescribing. Survivors on the board. Every recommendation traceable to NCCN, ASCO, or COG-LTFU guidance.
Dr. Lena Park, MD
Chief Medical Officer
Board-certified internal medicine + cardio-oncology. Former clinical lead at an academic survivorship program.
Dr. Marcus Hale, MD, PhD
Chair, Clinical Advisory Board
Medical oncology. 60+ peer-reviewed papers on long-term effects of cancer therapy and survivorship science.
Dr. Priya Anand, MD, MPH
Preventive Cardiology
ApoB-first lipid management. Cardio-oncology surveillance after anthracyclines and chest RT.
Dr. James O'Neil, PharmD, BCPS
Clinical Pharmacy
Deprescribing of treatment-era medications. Drug-drug interaction modeling for survivors.
Sara Whitman, RD, CSSD
Survivorship Nutrition
Sarcopenia recovery, bone-health nutrition after treatment, and post-treatment metabolic rebuild.
Rohan Mehta
Director, Institute Operations
Built patient-facing digital health platforms serving over a million users across three companies.
Safety & Compliance
Built for survivorship. Governed for trust.
Clinician-reviewed, guideline-aligned
Every surveillance plan is reviewed by a licensed clinician and mapped to NCCN, ASCO, and COG-LTFU guidance.
PHI access audit trail
Every view, export, and share of a survivor's chart is logged. Survivors can see who accessed their data and revoke access at any time.
HIPAA-ready infrastructure
Encrypted PHI at rest and in transit, SOC 2 Type II vendors, BAAs with every subprocessor, annual penetration testing. See our HIPAA readiness page for the current status of each feature.
Consent-scoped data sharing
Nothing leaves your account without an explicit action or an opt-in you can revoke. Automated FHIR sync is off until HIPAA readiness is complete.
Portable, patient-owned record
Your survivorship chart travels with you. Download it, share it, or hand a printable summary to any new clinician.
Independent clinical review
Protocols reviewed with our CSPN clinician network and refreshed against the peer-reviewed literature.
As featured in
“The first serious attempt to give every survivor a portable, guideline-aligned chart.”
“The Institute is doing for survivorship what patient-owned records tried to do a decade ago — and finally getting the design right.”
“A meaningful step toward closing the AYA transition-of-care cliff.”